Answers are grounded in this paper and cite their sources.
We describe a lung colony assay for measuring tumor immunity in mice. This assay is a useful alternative to the conventional method of counting the number of tumor “takes” after subcutaneous challenge with graded doses of tumor cells. Mice to be tested were challenged with tumor cells intravenously. Two weeks later the lungs were removed, and each lobe was separately fixed and embedded in flattened form (<1 mm thick). Sections were made at one~third and two-thirds the distance through the flattened lobes and stained with hematoxylin and eosin. The tumor cell colonies could then be easily seen and counted microscopically. Cells from a transplantable squamous cell carcinoma, a breast adenocarcinoma, and a fibrosarcoma were tested. The mean coefficient of variation of the colony count in the 2 sections through the flattened lobes was 12.8%. The lung-colonizing efficiency of the 3 tumor lines was 167–208 colonies/106 cells injected. The use of lung colony counts to assay tumor immunity was demonstrated with a transplantable simian virus 40-transformed fibrosarcoma and a tissue culture-transformed BALB/3T3 fibrosarcoma.
No takes yet. Share an insight, caveat, or question.
Boone et al. (1973) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: